Adaptive Biotechnologies Corp ADPT

$28.35 +0.98 (3.58%)

Valuation

Market cap
4,368,143,000
Revenue TTM
$276,980,000
Net income TTM
$-59,500,000
PE ratio
0.00
Forward PE
—
Profit margin
-21.48%
Debt to equity
0.00

Trading

Volume
1,575,400
Avg volume
2,344,318
Day's range
$27.31 – $28.41
Shares out
159,596,000
Stochastic %K
50%
Beta
2.09
Analysts
Strong Sell
Price target
$28.31

Price

Company profile

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects...

Show more

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
206 659 0067
Website
https://www.adaptivebiotech.com
Address
1165 Eastlake Avenue East, Seattle, United States

Latest news

Stocktwits

IrenGlazer69 Oct 1, 6:13 PM
$ADPT wtf is this
1 replies
IrenGlazer69 Oct 1, 5:50 PM
$ADPT chill pls
0 replies
Stocktwits52wHighs Sep 25, 5:16 PM
$ADPT printed a new 52-week high today
0 replies
Treasury225 Sep 24, 7:36 PM
$ADPT
0 replies
Treasury225 Sep 22, 7:54 PM
$ADPT $MYGN $WGS i notice more of this shit every day as AI tries to monetize itself.
0 replies
notreload_ai Sep 22, 5:06 PM
Craig-Hallum flags code confusion at $WGS, $ADPT and $MYGN, but says the $WGS drop looks overdone.
0 replies
Cryptoneous Sep 20, 2:08 PM
$ADPT will be a long term builder. Buy in and wait 5 years.
0 replies
Avocado_smash Sep 18, 1:21 AM
$ADPT
0 replies